Literature DB >> 2397394

The origin of remyelinating oligodendrocytes in antiserum-mediated demyelinative optic neuropathy.

W M Carroll1, A R Jennings, F L Mastaglia.   

Abstract

The origin of the remyelinating oligodendrocyte in a focal antigalactocerebroside-induced demyelinating lesion of the cat optic nerve was studied with detailed correlative electron microscopy and immunocytochemistry using a panel of antigenic markers. Within 10 days of the destruction of all endogenous oligodendrocytes and demyelination of all axons in the lesion, a new population of small glial cells appeared coincident with division of the residual astrocytes and developed a process-bearing axon-embracing morphology. The processes of these small glial cells (SGCs) contained intermediate filaments composed not of glial fibrillary acidic protein but of vimentin and over the ensuing 14 days these cells confirmed their oligodendrocyte destiny by differentiating to lose the intermediate filaments, form myelin and acquire the acquire the typical oligodendrocyte antigenic phenotype. It is suggested that the extensive remyelination of this lesion is sponsored by the new population of SGCs which in turn are generated either by dedifferentiated reactive astrocytes or by as yet unidentified precursor cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397394     DOI: 10.1093/brain/113.4.953

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  10 in total

Review 1.  Do oligodendrocytes divide?

Authors:  W T Norton
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

2.  Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells.

Authors:  G Wolswijk
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

Review 3.  Glial lineages and myelination in the central nervous system.

Authors:  A Compston; J Zajicek; J Sussman; A Webb; G Hall; D Muir; C Shaw; A Wood; N Scolding
Journal:  J Anat       Date:  1997-02       Impact factor: 2.610

4.  Evoked potentials as a biomarker of remyelination.

Authors:  Moones Heidari; Abigail B Radcliff; Gillian J McLellan; James N Ver Hoeve; Kore Chan; Julie A Kiland; Nicholas S Keuler; Benjamin K August; Dylan Sebo; Aaron S Field; Ian D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 5.  Glial Cells Shape Pathology and Repair After Spinal Cord Injury.

Authors:  Andrew D Gaudet; Laura K Fonken
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

6.  Ascl1 lineage cells contribute to ischemia-induced neurogenesis and oligodendrogenesis.

Authors:  Rui Lan Zhang; Michael Chopp; Cindi Roberts; Longfei Jia; Min Wei; Mei Lu; Xinli Wang; Siamak Pourabdollah; Zheng Gang Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

Review 7.  Therapeutic strategies in multiple sclerosis. II. Long-term repair.

Authors:  N Scolding
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 8.  Optic Neuritis in Multiple Sclerosis-A Review of Molecular Mechanisms Involved in the Degenerative Process.

Authors:  Manuela Andreea Ciapă; Delia Lidia Șalaru; Cristian Stătescu; Radu Andy Sascău; Camelia Margareta Bogdănici
Journal:  Curr Issues Mol Biol       Date:  2022-09-02       Impact factor: 2.976

9.  Sildenafil enhances neurogenesis and oligodendrogenesis in ischemic brain of middle-aged mouse.

Authors:  Rui Lan Zhang; Michael Chopp; Cynthia Roberts; Min Wei; Xinli Wang; Xianshuang Liu; Mei Lu; Zheng Gang Zhang
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

Review 10.  Brain repair.

Authors:  A Compston
Journal:  J R Coll Physicians Lond       Date:  1994 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.